Published in J Biol Chem on June 25, 1992
Structure of the proline dehydrogenase domain of the multifunctional PutA flavoprotein. Nat Struct Biol (2003) 1.76
PutA protein, a membrane-associated flavin dehydrogenase, acts as a redox-dependent transcriptional regulator. Proc Natl Acad Sci U S A (1993) 1.71
Autogenous regulation of gene expression. J Bacteriol (1993) 1.65
Structural biology of proline catabolism. Amino Acids (2008) 1.45
Structure and kinetics of monofunctional proline dehydrogenase from Thermus thermophilus. J Biol Chem (2007) 1.44
Structures of the Escherichia coli PutA proline dehydrogenase domain in complex with competitive inhibitors. Biochemistry (2004) 1.41
Regulation of gene expression by repressor localization: biochemical evidence that membrane and DNA binding by the PutA protein are mutually exclusive. J Bacteriol (1997) 1.31
Protein localization in Escherichia coli cells: comparison of the cytoplasmic membrane proteins ProP, LacY, ProW, AqpZ, MscS, and MscL. J Bacteriol (2009) 1.26
Identification and characterization of the DNA-binding domain of the multifunctional PutA flavoenzyme. J Biol Chem (2004) 1.25
Structural basis of the transcriptional regulation of the proline utilization regulon by multifunctional PutA. J Mol Biol (2008) 1.22
Redox-induced changes in flavin structure and roles of flavin N(5) and the ribityl 2'-OH group in regulating PutA--membrane binding. Biochemistry (2007) 1.21
Regulation of PutA-membrane associations by flavin adenine dinucleotide reduction. Biochemistry (2004) 1.17
Crystal structure of the bifunctional proline utilization A flavoenzyme from Bradyrhizobium japonicum. Proc Natl Acad Sci U S A (2010) 1.16
Steady-state kinetic mechanism of the proline:ubiquinone oxidoreductase activity of proline utilization A (PutA) from Escherichia coli. Arch Biochem Biophys (2011) 1.10
Crystal structures of the DNA-binding domain of Escherichia coli proline utilization A flavoprotein and analysis of the role of Lys9 in DNA recognition. Protein Sci (2006) 1.08
Characterization of a bifunctional PutA homologue from Bradyrhizobium japonicum and identification of an active site residue that modulates proline reduction of the flavin adenine dinucleotide cofactor. Biochemistry (2005) 1.06
Oxygen reactivity of PutA from Helicobacter species and proline-linked oxidative stress. J Bacteriol (2006) 1.06
Protein ProQ influences osmotic activation of compatible solute transporter ProP in Escherichia coli K-12. J Bacteriol (1999) 1.02
The structure of the proline utilization a proline dehydrogenase domain inactivated by N-propargylglycine provides insight into conformational changes induced by substrate binding and flavin reduction. Biochemistry (2010) 1.00
A conserved active site tyrosine residue of proline dehydrogenase helps enforce the preference for proline over hydroxyproline as the substrate. Biochemistry (2009) 1.00
Direct linking of metabolism and gene expression in the proline utilization A protein from Escherichia coli. Amino Acids (2008) 0.98
Rapid reaction kinetics of proline dehydrogenase in the multifunctional proline utilization A protein. Biochemistry (2011) 0.95
Substrate channeling in proline metabolism. Front Biosci (Landmark Ed) (2012) 0.94
An Escherichia coli reference collection group B2- and uropathogen-associated polymorphism in the rpoS-mutS region of the E. coli chromosome. J Bacteriol (2000) 0.93
Structural basis for the inactivation of Thermus thermophilus proline dehydrogenase by N-propargylglycine. Biochemistry (2008) 0.93
Flavin redox switching of protein functions. Antioxid Redox Signal (2010) 0.90
[delta]1-Pyrroline-5-Carboxylate Dehydrogenase from Cultured Cells of Potato (Purification and Properties). Plant Physiol (1997) 0.88
Unique structural features and sequence motifs of proline utilization A (PutA). Front Biosci (Landmark Ed) (2012) 0.88
Salinity-dependent impacts of ProQ, Prc, and Spr deficiencies on Escherichia coli cell structure. J Bacteriol (2014) 0.86
Solution structure of the Pseudomonas putida protein PpPutA45 and its DNA complex. Proteins (2009) 0.84
Small-angle X-ray scattering studies of the oligomeric state and quaternary structure of the trifunctional proline utilization A (PutA) flavoprotein from Escherichia coli. J Biol Chem (2011) 0.82
Ehrlichia chaffeensis proliferation begins with NtrY/NtrX and PutA/GlnA upregulation and CtrA degradation induced by proline and glutamine uptake. MBio (2014) 0.81
DNA inhibits catalysis by the carboxyltransferase subunit of acetyl-CoA carboxylase: implications for active site communication. Protein Sci (2008) 0.81
Evidence that the C-terminal domain of a type B PutA protein contributes to aldehyde dehydrogenase activity and substrate channeling. Biochemistry (2014) 0.79
Proline dehydrogenase is a positive regulator of cell death in different kingdoms. Plant Signal Behav (2011) 0.78
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Synthesis of methyl-mercury compounds by extracts of a methanogenic bacterium. Nature (1968) 4.01
Gene products that promote mRNA turnover in Saccharomyces cerevisiae. Mol Cell Biol (1992) 4.00
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res (2004) 3.95
Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol (2003) 3.23
Predictors of future falls in Parkinson disease. Neurology (2010) 3.00
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Biological cycles for toxic elements in the environment. Science (1974) 2.62
An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
The metabolism of protocatechuate by Pseudomonas testosteroni. Biochem J (1968) 2.41
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Genetics of L-proline utilization in Escherichia coli. J Bacteriol (1981) 2.37
The degradation of trans-ferulic acid by Pseudomonas acidovorans. Biochemistry (1970) 2.29
Proline transport and osmotic stress response in Escherichia coli K-12. J Bacteriol (1986) 2.29
Symbiotic properties of C4-dicarboxylic acid transport mutants of Rhizobium leguminosarum. J Bacteriol (1983) 2.19
Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America. Bull World Health Organ (1985) 2.18
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine (1994) 2.09
Oxybenzone oxidation following solar irradiation of skin: photoprotection versus antioxidant inactivation. J Invest Dermatol (1996) 2.07
Succinate transport in Rhizobium leguminosarum. J Bacteriol (1981) 2.04
Leucine transport in Escherichia coli. The resolution of multiple transport systems and their coupling to metabolic energy. J Biol Chem (1975) 2.02
The polymerisation of dietary sugars by dental plaque. Caries Res (1967) 1.96
Proline porter II is activated by a hyperosmotic shift in both whole cells and membrane vesicles of Escherichia coli K12. J Biol Chem (1988) 1.95
Isolation and sequencing of Escherichia coli gene proP reveals unusual structural features of the osmoregulatory proline/betaine transporter, ProP. J Mol Biol (1993) 1.94
The reaction of multihalogenated hydrocarbons with free and bound reduced vitamin B 12. Biochemistry (1968) 1.93
Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol (1991) 1.89
Mechanical properties of vesicles. II. A model for osmotic swelling and lysis. Biophys J (1993) 1.89
Biomethylation of toxic elements in the environment. Science (1977) 1.87
Formation of methane from serine by cell-free extracts of Methanobacillus omelianskii. J Biol Chem (1965) 1.85
The extracellular polysaccharide produced from sucrose by a cariogenic streptococcus. Arch Oral Biol (1966) 1.83
Biochemistry and regulation of a second L-proline transport system in Salmonella typhimurium. J Bacteriol (1980) 1.77
Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology (1978) 1.75
Osmoadaptation by rhizosphere bacteria. Annu Rev Microbiol (1996) 1.74
Two proline porters in Escherichia coli K-12. J Bacteriol (1983) 1.70
Kinetic and Mössbauer studies on the mechanism of protocatechuic acid 4,5-oxygenase. Biochemistry (1972) 1.64
Characterization of an inducible porter required for L-proline catabolism by Escherichia coli K12. Can J Biochem (1979) 1.60
The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis (1999) 1.58
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc (1999) 1.58
How do children tell? The disclosure process in child sexual abuse. Child Abuse Negl (1996) 1.55
Sequence analysis identifies the proline dehydrogenase and delta 1-pyrroline-5-carboxylate dehydrogenase domains of the multifunctional Escherichia coli PutA protein. J Mol Biol (1994) 1.52
Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology (1995) 1.51
Proline dehydrogenase from Escherichia coli K12. Properties of the membrane-associated enzyme. Eur J Biochem (1983) 1.50
Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48
Membrane association of proline dehydrogenase in Escherichia coli is redox dependent. Proc Natl Acad Sci U S A (1987) 1.48
Na+ (Li+)-proline cotransport in Escherichia coli. J Membr Biol (1985) 1.48
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Amplification of the put genes and identification of the put gene products in Escherichia coli K12. Can J Biochem (1980) 1.45
A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ (1975) 1.40
Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology (1993) 1.39
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin. Chem Biol (2000) 1.37
More than suggestion: the effect of interviewing techniques from the McMartin Preschool case. J Appl Psychol (1998) 1.35
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol (1999) 1.34
Biodegradation of natural and man-made recalcitrant compounds with particular reference to lignin. J Agric Food Chem (1977) 1.33
Conformational change and membrane association of the PutA protein are coincident with reduction of its FAD cofactor by proline. J Biol Chem (1993) 1.32
Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. Virology (1994) 1.28
Serial examination of the normal visual field using Octopus automated projection perimetry. Evidence for a learning effect. Acta Ophthalmol (Copenh) (1987) 1.26
Mechanical properties of vesicles. I. Coordinated analysis of osmotic swelling and lysis. Biophys J (1993) 1.26
Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond. J Med Chem (1989) 1.24
Factors reducing and promoting the effectiveness of proline as an osmoprotectant in Escherichia coli K12. J Gen Microbiol (1987) 1.23
Vistech VCTS 6500 charts--within- and between-session reliability. Optom Vis Sci (1991) 1.21
Strain-specificity of antibody to haemagglutinin following inactivated A/port chalmers/1/73 vaccine in man: evidence for a paradoxical strain-specific antibody response. Dev Biol Stand (1978) 1.20
Mechanisms for the biomethylation of metals and metalloids. Fed Proc (1978) 1.19
Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. J Hyg (Lond) (1983) 1.19
The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology (1990) 1.19
Purification and reconstitution of an osmosensor: transporter ProP of Escherichia coli senses and responds to osmotic shifts. Biochemistry (1999) 1.18
Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science (1994) 1.17
Early intermediates in the degradation of alpha-conidendrin by a Pseudomonas multivorans. Biochemistry (1970) 1.17
A dextransucrase activity from Streptococcus FA-1. Arch Oral Biol (1967) 1.16
Requirements for osmosensing and osmotic activation of transporter ProP from Escherichia coli. Biochemistry (2001) 1.14
The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun (1986) 1.14
Proline dehydrogenase from Escherichia coli K12. Reconstitution of a functional membrane association. J Biol Chem (1984) 1.14
Allegations of wrongdoing: the effects of reinforcement on children's mundane and fantastic claims. J Appl Psychol (2000) 1.14
Pituitary 45 Ca ion uptake and release of ACTH, GH, and TSH: effect of verapamil. Am J Physiol (1974) 1.13
Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J Gen Virol (1991) 1.13
Biochemical and morphological correlates of acute experimental myocardial ischemia in the dog. IV. Energy mechanisms during very early ischemia. Circ Res (1979) 1.13
Components required for the formation of CH-4 from methylcobalamin by extracts of Methanobacillus omelianskii. J Bacteriol (1966) 1.13
Propylation and purification of a B12 enzyme involved in methane formation. Biochemistry (1966) 1.12
Isolation of chlorine-containing antibiotic from the freshwater cyanobacterium Scytonema hofmanni. Science (1982) 1.12
Genetic and biochemical requirements for chemotaxis to L-proline in Escherichia coli. J Bacteriol (1981) 1.12
Insertion proQ220::Tn5 alters regulation of proline porter II, a transporter of proline and glycine betaine in Escherichia coli. J Bacteriol (1989) 1.11
Osmoregulatory transporter ProP influences colonization of the urinary tract by Escherichia coli. Microbiology (1998) 1.11
Influence of side-chain substituents on the position of cleavage of the benzene ring by Pseudomonas fluorescens. J Bacteriol (1969) 1.10
Effects of acidification on the mobility of metals and metalloids: an overview. Environ Health Perspect (1985) 1.10
Do generalized visual training programmes for sport really work? An experimental investigation. J Sports Sci (2001) 1.09
Wildlife surveillance associated with an outbreak of lethal H5N2 avian influenza in domestic poultry. Avian Dis (1985) 1.09
the involvement of Nitric Oxide in the inhibition of the phosphoroclastic system in Clostridium sporogenes by sodium nitrite. J Gen Microbiol (1981) 1.08
The incidence of enterotoxin production in strains of Staphylococcus aureus isolated from foods. J Appl Bacteriol (1974) 1.07
Reliability of high- and low-contrast letter charts. Ophthalmic Physiol Opt (1993) 1.07
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. J Hyg (Lond) (1983) 1.07
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. J Hyg (Lond) (1983) 1.06
Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol (1986) 1.06
The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses. J Gen Virol (1993) 1.06
Macrophage electrophoretic mobility (MEM) with myelin basic protein. Br J Cancer (1976) 1.05
Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J Hyg (Lond) (1983) 1.05
The ion coupling and organic substrate specificities of osmoregulatory transporter ProP in Escherichia coli. Biochim Biophys Acta (1999) 1.05
Melanin protects melanocytes and keratinocytes against H2O2-induced DNA strand breaks through its ability to bind Ca2+. Exp Cell Res (2004) 1.04
Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun (2007) 1.04
The standardization of inactivated equine influenza vaccines by single-radial immunodiffusion. J Biol Stand (1983) 1.04
Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension (1992) 1.03
Protein ProQ influences osmotic activation of compatible solute transporter ProP in Escherichia coli K-12. J Bacteriol (1999) 1.02